{"id":"W2077531651","doi":"10.1056/nejmoa1215739","title":"Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease","year":2013,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2687,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; University of Alberta; Western University","funders":"Takeda Pharmaceuticals International","keywords":"Vedolizumab; Maintenance therapy; Crohn's disease; Induction therapy; Medicine; Disease; Intensive care medicine; Internal medicine; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}